Suchergebnisse - "Leukemia/pathology"

  1. 1
  2. 2
  3. 3

    Quelle: J Cancer Res Clin Oncol

  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Quelle: Oncotarget. 6:17698-17712

  10. 10

    Quelle: Collegium antropologicum
    CODEN COANDS
    Volume 34
    Issue 2

    Dateibeschreibung: application/pdf

  11. 11

    Quelle: Cell Biochem Biophys

  12. 12
  13. 13
  14. 14
  15. 15

    Weitere Verfasser: Woo Ick Yang Tae Sung Park Jin Seok Kim et al.

    Quelle: Cancer Genetics and Cytogenetics. 181:93-99

    Dateibeschreibung: 93~99

  16. 16
  17. 17

    Quelle: Journal of Endocrinology. 192:199-205

    Dateibeschreibung: 2 full-text file(s): application/pdf; application/pdf

  18. 18

    Quelle: Expert opinion on pharmacotherapy

    Schlagwörter: Drug dose regimen, Hydrocortisone, Carcinogenesis, Life expectancy, Dermatitis, Review, Antipyretic agent, Diagnostic accuracy, Dna topoisomerases, Breast cancer, 0302 clinical medicine, Leukoencephalopathy, Antineoplastic agents, Meningeal Neoplasms, Enzyme Inhibitors, Cerebrospinal fluid analysis, Injections, Spinal, Adenocarcinoma/pathology, Enzyme Inhibitors/therapeutic use, Palliative Care, Headache, Prognosis, Antineoplastic, Alkylating, Management, 3. Good health, Clinical trial, Nuclear magnetic resonance imaging, Arachnoid Cysts, Spinal cord disease, Randomized controlled trials, Reverse transcription polymerase chain reaction, fluid/therapeutic use, Topotecan/therapeutic use, Rituximab, Lymphoma/pathology, Human, Antimetabolites, Antineoplastic, Leptomeninx, Bone marrow suppression, Vomiting, Leptomeningeal, Adenocarcinoma, Irinotecan, Beta 2 microglobulin, 03 medical and health sciences, Disease association, Drug formulation, Meningism, Humans, Molecular mechanics, High risk population, Steroid, Antineoplastic Agents, Alkylating, Carcinoma/*drug therapy/radiotherapy/secondary, Type i, Myelin basic protein, Methotrexate, Arachnoiditis, Laboratory diagnosis, Delayed-Action Preparations, Risk factor, Topoisomerase I Inhibitors, Lymphoma, Antimetabolites, Meningeal Neoplasms/*drug therapy/radiotherapy/secondary, Dexamethasone, Cancer risk, Arachnoid cysts, Photophobia, Thiotepa/administration & dosage/cerebrospinal fluid/therapeutic use, Nephrotoxicity, Meningeal metastasis, Randomized Controlled Trials as Topic, Leukemia, Cytarabine, Folinic acid, Lactate dehydrogenase, Nausea, Combined modality therapy, Enzyme inhibitors, Antineoplastic Agents, Alkylating/administration & dosage/cerebrospinal, Combined Modality Therapy, Sensitivity and specificity, Cranial irradiation, Injections, Intravenous, Palliative care, Cytarabine/administration & dosage/cerebrospinal fluid/therapeutic use, Meningeal neoplasms, Mafosfamide, Intravenous, Carcinomatous meningitis, Algorithms, Drug elimination, Fever, Spinal, Liver toxicity, Drug response, Cerebellum disease, Drug half life, Neuroimaging, Arachnoid Cysts/*drug therapy/etiology/radiotherapy, Injections, Aseptic meningitis, Methotrexate/administration & dosage/cerebrospinal fluid/therapeutic use, Mucosa inflammation, Computer assisted tomography, Temozolomide, Leukemia/pathology, Antimetabolites, Antineoplastic/administration & dosage/cerebrospinal, Vasculotropin, Carcinoma, Malignancy, Trastuzumab, Cancer survival, Drug efficacy, Carcinoembryonic antigen, Delayed-action preparations, Cranial Irradiation, Antiemetic agent, Topotecan, Cytology, Thiotepa

  19. 19

    Weitere Verfasser: Jeon Han Park Jongsun Kim Hyun Joo Park et al.

    Quelle: Cancer Immunology, Immunotherapy. 53:461-470

    Dateibeschreibung: 461~470

  20. 20

    Quelle: Journal of Neuroimmunology. 149:167-181

    Schlagwörter: 0301 basic medicine, Adenosine Triphosphate -- pharmacology, Time Factors, Myeloid Cells -- drug effects, Leukemia -- pathology, Electrophoretic Mobility Shift Assay, Signal Transduction -- drug effects, Transcription Factor AP-1 -- metabolism, Cytarabine -- pharmacology, Neuropeptides -- genetics, Adenosine Triphosphate, Cytosol, Vasoactive Intestinal Peptide -- genetics, Enzyme Inhibitors -- pharmacology, Receptors, Glycophorin -- metabolism, Cyclic AMP, Drug Interactions, Bromodeoxyuridine -- metabolism, Cytosol -- metabolism, Glycophorins, Enzyme Inhibitors, Estrenes, Tetradecanoylphorbol Acetate -- analogs & derivatives, 0303 health sciences, Tumor, Cytarabine, Sciences bio-médicales et agricoles, Flow Cytometry, Intercellular Adhesion Molecule-1, Vasoactive Intestinal Peptide -- pharmacology, 3. Good health, Pituitary Adenylate Cyclase-Activating Polypeptide, Drug, Immunosuppressive Agents -- pharmacology, Immunosuppressive Agents, Protein Binding, Proto-Oncogene Proteins -- genetics, Inositol Phosphates, Enzyme-Linked Immunosorbent Assay, DNA Fragmentation, Cell Line, Dose-Response Relationship, 03 medical and health sciences, Intercellular Adhesion Molecule-1 -- metabolism, Cell Line, Tumor, Humans, Neuropeptides -- pharmacology, Messenger -- biosynthesis, Electrophoretic Mobility Shift Assay -- methods, DNA Fragmentation -- drug effects, Flow Cytometry -- methods, Dose-Response Relationship, Drug, Estrenes -- pharmacology, Inositol Phosphates -- metabolism, Thrombin -- pharmacology, Enzyme-Linked Immunosorbent Assay -- methods, Tetradecanoylphorbol Acetate -- pharmacokinetics, Proto-Oncogene Proteins -- metabolism, Bromodeoxyuridine, Pyrrolidinones -- pharmacology, Calcium -- metabolism, RNA, Calcium, Cyclic AMP -- metabolism, Vasoactive Intestinal Peptide -- metabolism, Reverse Transcriptase Polymerase Chain Reaction -- methods, Myeloid Cells -- metabolism

    Dateibeschreibung: 1 full-text file(s): application/pdf